These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30010037)

  • 1. Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India.
    Sadaf ; Habib M; Khan MA; Najm MZ; Mallick MN; Sunita K; Shukla NK; Deo SVS; Husain SA
    Gene; 2018 Nov; 676():156-163. PubMed ID: 30010037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.
    Goel H; Singhal S; Mathur R; Syeda S; Gupta RK; Kumar A; Shrivastava A; Jha AK
    Asian Pac J Cancer Prev; 2020 May; 21(5):1283-1287. PubMed ID: 32458634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers.
    Takahashi Y; Miyoshi Y; Takahata C; Irahara N; Taguchi T; Tamaki Y; Noguchi S
    Clin Cancer Res; 2005 Feb; 11(4):1380-5. PubMed ID: 15746036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of large tumor suppressor homolog 2 gene and its promotor methylation in oral squamous cell carcinoma].
    Yue ZW; Liu JZ
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2017 Sep; 52(9):569-573. PubMed ID: 29972924
    [No Abstract]   [Full Text] [Related]  

  • 5. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
    Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter Hypermethylation of Genes Encoding for RASSF/Hippo Pathway Members Reveals Specific Alteration Pattern in Diffuse Gliomas.
    Levallet G; Creveuil C; Bekaert L; Péres E; Planchard G; Lecot-Cotigny S; Guillamo JS; Emery E; Zalcman G; Lechapt-Zalcman E
    J Mol Diagn; 2019 Jul; 21(4):695-704. PubMed ID: 31055025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of MGMT in correlation with aberrant DNA methylation in esophageal cancer patients from North India.
    Rehman AU; Saikia S; Iqbal MA; Ahmad I; Sadaf ; Anees A; Aravinda PS; Mishra PK; Hedau S; Saluja SS; Medhi S; Husain SA
    Tumour Biol; 2017 Jun; 39(6):1010428317705770. PubMed ID: 28621225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.
    Li W; Wang L; Katoh H; Liu R; Zheng P; Liu Y
    Cancer Res; 2011 Mar; 71(6):2162-71. PubMed ID: 21278236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Alterations and Expression Dynamics of LATS1 and LATS2 Genes in Non-Small-Cell Lung Carcinoma.
    Malik SA; Khan MS; Dar M; Hussain MU; Shah MA; Shafi SM; Mudassar S
    Pathol Oncol Res; 2018 Apr; 24(2):207-214. PubMed ID: 28434174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LATS2 is de-methylated and overexpressed in nasopharyngeal carcinoma and predicts poor prognosis.
    Zhang Y; Hu CF; Chen J; Yan LX; Zeng YX; Shao JY
    BMC Cancer; 2010 Oct; 10():538. PubMed ID: 20932276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low LATS2 mRNA level can predict favorable response to epirubicin plus cyclophosphamide, but not to docetaxel, in breast cancers.
    Takahashi Y; Miyoshi Y; Morimoto K; Taguchi T; Tamaki Y; Noguchi S
    J Cancer Res Clin Oncol; 2007 Aug; 133(8):501-9. PubMed ID: 17297610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
    Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large tumor suppressor 2 is a prognostic biomarker and correlated with immune infiltrates in colorectal cancer.
    Zhao C; Chen J; Liu Y; Ju S; Wang G; Wang X
    Bioengineered; 2021 Dec; 12(2):11648-11661. PubMed ID: 34699318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of RASSF1A gene methylation on clinico-pathological features of tumor and non-tumor tissue of breast cancer.
    Gupta V; Agarwal P; Deshpande P
    Ann Diagn Pathol; 2021 Jun; 52():151722. PubMed ID: 33621744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma.
    Jiang Z; Li X; Hu J; Zhou W; Jiang Y; Li G; Lu D
    Neurosci Res; 2006 Dec; 56(4):450-8. PubMed ID: 17049657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
    Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
    Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between HIC1 and RASSF1A promoter hypermethylation with MTHFD1 G1958A polymorphism and clinicopathological features of breast cancer in Iranian patients.
    Rasti M; Tavasoli P; Monabati A; Entezam M
    Iran Biomed J; 2009 Oct; 13(4):199-206. PubMed ID: 19946345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
    Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.